217 related articles for article (PubMed ID: 20452143)
41. Variations in magnitude and directionality of respiratory target motion throughout full treatment courses of stereotactic body radiotherapy for tumors in the liver.
Worm ES; Høyer M; Fledelius W; Hansen AT; Poulsen PR
Acta Oncol; 2013 Oct; 52(7):1437-44. PubMed ID: 23879645
[TBL] [Abstract][Full Text] [Related]
42. The impact of respiratory gating on lung dosimetry in stereotactic body radiotherapy for lung cancer.
Jang SS; Huh GJ; Park SY; Yang PS; Cho EY
Phys Med; 2014 Sep; 30(6):682-9. PubMed ID: 24933003
[TBL] [Abstract][Full Text] [Related]
43. Asymmetric margin setting at the cranial and caudal sides in respiratory gated and non-gated stereotactic body radiotherapy for lung cancer.
Ueda Y; Oohira S; Isono M; Miyazaki M; Teshima T
Br J Radiol; 2016; 89(1059):20150499. PubMed ID: 26693594
[TBL] [Abstract][Full Text] [Related]
44. Do maximum intensity projection images truly capture tumor motion?
Park K; Huang L; Gagne H; Papiez L
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):618-25. PubMed ID: 19147026
[TBL] [Abstract][Full Text] [Related]
45. Feasibility of using intravenous contrast-enhanced computed tomography (CT) scans in lung cancer treatment planning.
Xiao J; Zhang H; Gong Y; Fu Y; Tang B; Wang S; Jiang Q; Li P
Radiother Oncol; 2010 Jul; 96(1):73-7. PubMed ID: 20347496
[TBL] [Abstract][Full Text] [Related]
46. A novel simple approach for incorporation of respiratory motion in stereotactic treatments of lung tumors.
Cuijpers JP; Verbakel WF; Slotman BJ; Senan S
Radiother Oncol; 2010 Dec; 97(3):443-8. PubMed ID: 21047693
[TBL] [Abstract][Full Text] [Related]
47. On the use of EPID-based implanted marker tracking for 4D radiotherapy.
Keall PJ; Todor AD; Vedam SS; Bartee CL; Siebers JV; Kini VR; Mohan R
Med Phys; 2004 Dec; 31(12):3492-9. PubMed ID: 15651632
[TBL] [Abstract][Full Text] [Related]
48. Deviations in delineated GTV caused by artefacts in 4DCT.
Persson GF; Nygaard DE; Brink C; Jahn JW; Munck af Rosenschöld P; Specht L; Korreman SS
Radiother Oncol; 2010 Jul; 96(1):61-6. PubMed ID: 20570002
[TBL] [Abstract][Full Text] [Related]
49. A comparison of the different 3D CT scanning modes on the GTV delineation for the solitary pulmonary lesion.
Shang DP; Liu CX; Yin Y
Radiat Oncol; 2014 Nov; 9():211. PubMed ID: 25391554
[TBL] [Abstract][Full Text] [Related]
50. Intra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumors.
Guckenberger M; Meyer J; Wilbert J; Richter A; Baier K; Mueller G; Flentje M
Radiother Oncol; 2007 Apr; 83(1):57-64. PubMed ID: 17306394
[TBL] [Abstract][Full Text] [Related]
51. Predicting tumour motion during the whole radiotherapy treatment: a systematic approach for thoracic and abdominal lesions based on real time MR.
Cusumano D; Dhont J; Boldrini L; Chiloiro G; Teodoli S; Massaccesi M; Fionda B; Cellini F; Azario L; Vandemeulebroucke J; De Spirito M; Valentini V; Verellen D
Radiother Oncol; 2018 Dec; 129(3):456-462. PubMed ID: 30144955
[TBL] [Abstract][Full Text] [Related]
52. Reproducibility of tumor motion probability distribution function in stereotactic body radiation therapy of lung cancer.
Zhang F; Hu J; Kelsey CR; Yoo D; Yin FF; Cai J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):861-6. PubMed ID: 22494586
[TBL] [Abstract][Full Text] [Related]
53. Analysis of Lung Tumor Motion in a Large Sample: Patterns and Factors Influencing Precise Delineation of Internal Target Volume.
Knybel L; Cvek J; Molenda L; Stieberova N; Feltl D
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):751-758. PubMed ID: 27788948
[TBL] [Abstract][Full Text] [Related]
54. Dosimetric impact of online correction via cone-beam CT-based image guidance for stereotactic lung radiotherapy.
Galerani AP; Grills I; Hugo G; Kestin L; Mohammed N; Chao KK; Suen A; Martinez A; Yan D
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1571-8. PubMed ID: 20646857
[TBL] [Abstract][Full Text] [Related]
55. Deep learning-based target decomposition for markerless lung tumor tracking in radiotherapy.
Fu Y; Zhang P; Fan Q; Cai W; Pham H; Rimner A; Cuaron J; Cervino L; Moran JM; Li T; Li X
Med Phys; 2024 Jun; 51(6):4271-4282. PubMed ID: 38507259
[TBL] [Abstract][Full Text] [Related]
56. 4D imaging for target definition in stereotactic radiotherapy for lung cancer.
Slotman BJ; Lagerwaard FJ; Senan S
Acta Oncol; 2006; 45(7):966-72. PubMed ID: 16982565
[TBL] [Abstract][Full Text] [Related]
57. Inter- and intrafractional localisation errors in cone-beam CT guided stereotactic radiation therapy of tumours in the liver and lung.
Worm ES; Hansen AT; Petersen JB; Muren LP; Præstegaard LH; Høyer M
Acta Oncol; 2010 Oct; 49(7):1177-83. PubMed ID: 20590367
[TBL] [Abstract][Full Text] [Related]
58. An initial study on the estimation of time-varying volumetric treatment images and 3D tumor localization from single MV cine EPID images.
Mishra P; Li R; Mak RH; Rottmann J; Bryant JH; Williams CL; Berbeco RI; Lewis JH
Med Phys; 2014 Aug; 41(8):081713. PubMed ID: 25086523
[TBL] [Abstract][Full Text] [Related]
59. Pancreatic tumor motion on a single planning 4D-CT does not correlate with intrafraction tumor motion during treatment.
Minn AY; Schellenberg D; Maxim P; Suh Y; McKenna S; Cox B; Dieterich S; Xing L; Graves E; Goodman KA; Chang D; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):364-8. PubMed ID: 19398901
[TBL] [Abstract][Full Text] [Related]
60. Intra- and interfractional variations in geometric arrangement between lung tumours and implanted markers.
Ueki N; Matsuo Y; Nakamura M; Mukumoto N; Iizuka Y; Miyabe Y; Sawada A; Mizowaki T; Kokubo M; Hiraoka M
Radiother Oncol; 2014 Mar; 110(3):523-8. PubMed ID: 24560763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
